HEADER LECTIN 22-JUN-03 1OIO TITLE GAFD (F17C-TYPE) FIMBRIAL ADHESIN FROM ESCHERICHIA COLI COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIMBRIAL LECTIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 23-200; COMPND 5 SYNONYM: GAFD; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: 2 NAG (GLCNAC) MOLECULES PER MONOMER DISULPHIDE COMPND 8 BETWEEN C53 AND C110 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: ETEC STRAINS; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET-22B(+); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGAFD(1-178); SOURCE 10 OTHER_DETAILS: RESIDUES 1-178 KEYWDS LECTIN, ADHESIN, N-ACETYL-D-GLUCOSAMINE BINDING, GLCNAC BINDING KEYWDS 2 LECTIN EXPDTA X-RAY DIFFRACTION AUTHOR M.C.MERCKEL,J.TANSKANEN,S.EDELMAN,B.WESTERLUND-WIKSTROM,T.K.KORHONEN, AUTHOR 2 A.GOLDMAN REVDAT 4 06-NOV-24 1OIO 1 HETSYN REVDAT 3 29-JUL-20 1OIO 1 COMPND REMARK HETNAM SITE REVDAT 2 24-FEB-09 1OIO 1 VERSN REVDAT 1 15-AUG-03 1OIO 0 JRNL AUTH M.C.MERCKEL,J.TANSKANEN,S.EDELMAN,B.WESTERLUND-WIKSTROM, JRNL AUTH 2 T.K.KORHONEN,A.GOLDMAN JRNL TITL THE STRUCTURAL BASIS OF RECEPTOR-BINDING BY ESCHERICHIA COLI JRNL TITL 2 ASSOCIATED WITH DIARRHEA AND SEPTICEMIA JRNL REF J.MOL.BIOL. V. 331 897 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12909017 JRNL DOI 10.1016/S0022-2836(03)00841-6 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1159682.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.8 REMARK 3 NUMBER OF REFLECTIONS : 63688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.700 REMARK 3 FREE R VALUE TEST SET COUNT : 6186 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8726 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 981 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.008 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2684 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 236 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.65000 REMARK 3 B22 (A**2) : -0.14000 REMARK 3 B33 (A**2) : 0.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.46000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 28.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OIO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1290012936. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CONFOCAL MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84352 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 42.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 6000 100 MM HEPES PH 7.5, 5% REMARK 280 MPD, 5% GLCNAC, PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.23500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ALA B 135 O1 NAG B 202 1655 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR B 114 174.12 175.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. DBREF 1OIO A 1 178 UNP Q47341 Q47341 23 200 DBREF 1OIO B 1 178 UNP Q47341 Q47341 23 200 SEQRES 1 A 178 ALA VAL SER PHE ILE GLY SER THR GLU ASN ASP VAL GLY SEQRES 2 A 178 PRO SER GLN GLY SER TYR SER SER THR HIS ALA MET ASP SEQRES 3 A 178 ASN LEU PRO PHE VAL TYR ASN THR GLY TYR ASN ILE GLY SEQRES 4 A 178 TYR GLN ASN ALA ASN VAL TRP ARG ILE SER GLY GLY PHE SEQRES 5 A 178 CYS VAL GLY LEU ASP GLY LYS VAL ASP LEU PRO VAL VAL SEQRES 6 A 178 GLY SER LEU ASP GLY GLN SER ILE TYR GLY LEU THR GLU SEQRES 7 A 178 GLU VAL GLY LEU LEU ILE TRP MET GLY ASP THR ASN TYR SEQRES 8 A 178 SER ARG GLY THR ALA MET SER GLY ASN SER TRP GLU ASN SEQRES 9 A 178 VAL PHE SER GLY TRP CYS VAL GLY ASN TYR VAL SER THR SEQRES 10 A 178 GLN GLY LEU SER VAL HIS VAL ARG PRO VAL ILE LEU LYS SEQRES 11 A 178 ARG ASN SER SER ALA GLN TYR SER VAL GLN LYS THR SER SEQRES 12 A 178 ILE GLY SER ILE ARG MET ARG PRO TYR ASN GLY SER SER SEQRES 13 A 178 ALA GLY SER VAL GLN THR THR VAL ASN PHE SER LEU ASN SEQRES 14 A 178 PRO PHE THR LEU ASN ASP THR VAL THR SEQRES 1 B 178 ALA VAL SER PHE ILE GLY SER THR GLU ASN ASP VAL GLY SEQRES 2 B 178 PRO SER GLN GLY SER TYR SER SER THR HIS ALA MET ASP SEQRES 3 B 178 ASN LEU PRO PHE VAL TYR ASN THR GLY TYR ASN ILE GLY SEQRES 4 B 178 TYR GLN ASN ALA ASN VAL TRP ARG ILE SER GLY GLY PHE SEQRES 5 B 178 CYS VAL GLY LEU ASP GLY LYS VAL ASP LEU PRO VAL VAL SEQRES 6 B 178 GLY SER LEU ASP GLY GLN SER ILE TYR GLY LEU THR GLU SEQRES 7 B 178 GLU VAL GLY LEU LEU ILE TRP MET GLY ASP THR ASN TYR SEQRES 8 B 178 SER ARG GLY THR ALA MET SER GLY ASN SER TRP GLU ASN SEQRES 9 B 178 VAL PHE SER GLY TRP CYS VAL GLY ASN TYR VAL SER THR SEQRES 10 B 178 GLN GLY LEU SER VAL HIS VAL ARG PRO VAL ILE LEU LYS SEQRES 11 B 178 ARG ASN SER SER ALA GLN TYR SER VAL GLN LYS THR SER SEQRES 12 B 178 ILE GLY SER ILE ARG MET ARG PRO TYR ASN GLY SER SER SEQRES 13 B 178 ALA GLY SER VAL GLN THR THR VAL ASN PHE SER LEU ASN SEQRES 14 B 178 PRO PHE THR LEU ASN ASP THR VAL THR HET NAG A 201 15 HET NAG A 202 15 HET NAG B 201 15 HET NAG B 202 15 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 7 HOH *236(H2 O) HELIX 1 1 ASN A 90 SER A 92 5 3 HELIX 2 2 ASN B 90 GLY B 94 5 5 SHEET 1 AA 4 VAL A 2 PHE A 4 0 SHEET 2 AA 4 GLY A 39 SER A 49 -1 O ARG A 47 N SER A 3 SHEET 3 AA 4 VAL A 115 ILE A 128 -1 O SER A 116 N ILE A 48 SHEET 4 AA 4 PHE A 30 VAL A 31 -1 O PHE A 30 N ILE A 128 SHEET 1 AB 4 VAL A 2 PHE A 4 0 SHEET 2 AB 4 GLY A 39 SER A 49 -1 O ARG A 47 N SER A 3 SHEET 3 AB 4 VAL A 115 ILE A 128 -1 O SER A 116 N ILE A 48 SHEET 4 AB 4 VAL A 80 GLY A 87 -1 O GLY A 81 N VAL A 127 SHEET 1 AC 5 GLU A 9 VAL A 12 0 SHEET 2 AC 5 THR A 163 LEU A 168 1 O ASN A 165 N ASN A 10 SHEET 3 AC 5 THR A 142 PRO A 151 -1 O THR A 142 N LEU A 168 SHEET 4 AC 5 CYS A 53 VAL A 60 -1 O GLY A 55 N ARG A 150 SHEET 5 AC 5 GLU A 103 CYS A 110 -1 O GLU A 103 N GLY A 58 SHEET 1 AD 3 GLY A 17 ALA A 24 0 SHEET 2 AD 3 PHE A 171 THR A 178 1 O THR A 172 N TYR A 19 SHEET 3 AD 3 ALA A 135 VAL A 139 -1 O ALA A 135 N ASP A 175 SHEET 1 BA 4 VAL B 2 PHE B 4 0 SHEET 2 BA 4 GLY B 39 ILE B 48 -1 O ARG B 47 N SER B 3 SHEET 3 BA 4 SER B 116 ILE B 128 -1 O SER B 116 N ILE B 48 SHEET 4 BA 4 PHE B 30 VAL B 31 -1 O PHE B 30 N ILE B 128 SHEET 1 BB 4 VAL B 2 PHE B 4 0 SHEET 2 BB 4 GLY B 39 ILE B 48 -1 O ARG B 47 N SER B 3 SHEET 3 BB 4 SER B 116 ILE B 128 -1 O SER B 116 N ILE B 48 SHEET 4 BB 4 VAL B 80 GLY B 87 -1 O GLY B 81 N VAL B 127 SHEET 1 BC 5 GLU B 9 VAL B 12 0 SHEET 2 BC 5 THR B 163 LEU B 168 1 O ASN B 165 N ASN B 10 SHEET 3 BC 5 THR B 142 PRO B 151 -1 O THR B 142 N LEU B 168 SHEET 4 BC 5 CYS B 53 VAL B 60 -1 O GLY B 55 N ARG B 150 SHEET 5 BC 5 GLU B 103 CYS B 110 -1 O GLU B 103 N GLY B 58 SHEET 1 BD 3 GLY B 17 ALA B 24 0 SHEET 2 BD 3 PHE B 171 THR B 178 1 O THR B 172 N TYR B 19 SHEET 3 BD 3 ALA B 135 VAL B 139 -1 O ALA B 135 N ASP B 175 SSBOND 1 CYS A 53 CYS A 110 1555 1555 2.03 SSBOND 2 CYS B 53 CYS B 110 1555 1555 2.04 CISPEP 1 LEU A 28 PRO A 29 0 -0.12 CISPEP 2 LEU B 28 PRO B 29 0 -0.26 CRYST1 42.990 70.470 56.110 90.00 104.49 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023261 0.000000 0.006011 0.00000 SCALE2 0.000000 0.014190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018408 0.00000